Matsuyama, Ryutaro
99  Ergebnisse:
Personensuche X
?
 
?
3

Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on B..:

Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei...
Annals of Surgical Oncology.  29 (2022)  4 - p. 2393-2405 , 2022
 
?
4

Real-world analysis of apalutamide-associated skin adverse ..:

Tohi, Yoichiro ; Kato, Takuma ; Fukuhara, Hideo...
International Journal of Clinical Oncology.  27 (2022)  8 - p. 1348-1355 , 2022
 
?
5

ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuv..:

Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei...
Annals of Surgical Oncology.  29 (2022)  4 - p. 2406-2406 , 2022
 
?
7

Colocalization of GPR120 and anterior pituitary hormone-pro..:

NAKAMURA, Sho ; NODA, Kohei ; MIWA, Masafumi...
Journal of Reproduction and Development.  66 (2020)  2 - p. 135-141 , 2020
 
?
8

Prophylactic drain management after pancreaticoduodenectomy..:

Taniguchi, Koichi ; Matsuyama, Ryusei ; Yabushita, Yasuhiro...
Journal of Hepato-Biliary-Pancreatic Sciences.  27 (2020)  12 - p. 950-961 , 2020
 
?
 
?
 
?
14

Outcomes of surgery for 2010 WHO classification-based intra..:

Harada, Fumi ; Matsuyama, Ryusei ; Mori, Ryutaro...
European Journal of Surgical Oncology.  45 (2019)  5 - p. 761-768 , 2019
 
?
15

Single-institution experience with gemcitabine–cisplatin co..:

Matsuyama, Ryusei ; Morioka, Daisuke ; Mori, Ryutaro...
Cancer Chemotherapy and Pharmacology.  81 (2018)  5 - p. 949-955 , 2018
 
1-15